Government supplementary budget for COVID-19 medical and pharma measures Japan 2020

The Japanese government announced the supplementary budged related to the economic stimulus package concerning coronavirus disease (COVID-19) on April 20, 2020. A total expense of around 1.8 trillion Japanese yen was planned for medical and pharmaceutical related measures, 13.9 billion yen of which were for securing the antiviral drug Avigan (Favipiravir). Only 10 billion yen were for supporting the development of vaccines in the country, while close to 22 billion yen were prepared for supporting the development of vaccines internationally.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated facts and figures page.

Breakdown of governmental supplementary budget for medical and pharmaceutical related measures against coronavirus disease (COVID-19) in Japan announced on April 20, 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until November 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2020

Region

Japan

Survey time period

April 20, 2020

Supplementary notes

*To be allocated for measures implemented by local governments regarding Emergency Economic Package, depending on circumstances.
**Includes grants for PCR screening devices, securing hospital beds and facilities for patients with slight symptoms, securing medical equipment, or assisting dispatch of supporting doctors, etc.
***Such as distributing masks to kindergartens, elementary schools, nursing homes, and other facilities.

1 Japanese yen equals 0.0094 U.S. dollars or 0.0085 euros as of May 2020.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Coronavirus (COVID-19) in Japan"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.